HIV and Liver Disease 2021
September 9-11, 2021

Liver disease has emerged as a major cause of morbidity and mortality in individuals infected with HIV, including those infected with HBV and HCV. The HIV & Liver Disease 2021 conference is designed to address the increasingly prevalent clinical issues and challenges associated with HIV and liver disease. The conference brings together internationally renowned experts and clinicians from a variety of disciplines, including hepatology and infectious diseases, who will present and discuss the most current and clinically relevant information pertinent to improving patient outcomes.

The format of the conference provides a unique opportunity for both a formal and informal exchange of information. This year the conference will be held live, in-person, and live, virtually. It features General sessions, with presentations by faculty experts, Meet-the Professor lunch roundtable discussions, Oral presentations, and Poster presentations.

The conference will be held at Snake River Lodge, Teton Village, Wyoming. 
read more »

For sponsorship and table-top exhibit opportunities, please contact Amber Lovett at

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.

Funding for this conference was made possible [in part] by the National Institutes of Health under Award Number R13AI071925 from the National Institute of Allery and Infectious Diseases (NIAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Supported by educational grants from: Abbott Laboratories, Gilead, Theratechnologies, and ViiV

2016 Presentations
Sponsored by University of Cincinnati

Important Dates:

Registration - Now Open!
Abstract Submission - Now Open!
Submission Deadline - July 28, 2021
Housing Deadline - August 6, 2021

Kenneth E. Sherman, MD, PhD
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Organizing Committee 
Marion Peters, MD
Chief of Hepatology Research
University of California San Francisco
San Francisco, California

David Thomas, MD, MPH
Chief, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland